Typicality: | 0.501 |
Saliency: | 0.209 |
after signing the informed consent | 5 | temporal |
in approved clinics | 2 | location |
compared to normal weight lean women | 2 | other |
subject → be screened for → eligibility | 11 |
subject → be evaluated for → eligibility | 4 |
negative | neutral | positive |
0.099 | 0.868 | 0.033 |
Raw frequency | 15 |
Normalized frequency | 0.209 |
Modifier score | 1.000 |
Perplexity | 29.389 |